Financial News
FDA Staff Don’t Take Position on Moderna COVID-19 Booster
October 12, 2021 at 12:19 PM EDT
Food and Drug Administration staffers in an unusual move didn’t take a stance on Moderna Inc.’s MRNA +0.72% application for a booster dose, indicating there may not be sufficient data to support the extra dose.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
